466 related articles for article (PubMed ID: 2022591)
1. Immunologic abnormalities in HIV infection.
Zunich KM; Lane HC
Hematol Oncol Clin North Am; 1991 Apr; 5(2):215-28. PubMed ID: 2022591
[TBL] [Abstract][Full Text] [Related]
2. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
Aiuti F; Mezzaroma I
AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
[TBL] [Abstract][Full Text] [Related]
3. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
4. Immunoregulation, immune defects, and clinical strategies in HIV infection.
Lane HC
Mt Sinai J Med; 1992 May; 59(3):244-52. PubMed ID: 1534869
[TBL] [Abstract][Full Text] [Related]
5. The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells.
Gehri R; Hahn S; Rothen M; Steuerwald M; Nuesch R; Erb P
AIDS; 1996 Jan; 10(1):9-16. PubMed ID: 8924258
[TBL] [Abstract][Full Text] [Related]
6. CD4+ T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection.
Netski DM; Mosbruger T; Astemborski J; Mehta SH; Thomas DL; Cox AL
J Infect Dis; 2007 Mar; 195(6):857-63. PubMed ID: 17299716
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children.
Stricker K; Knipping E; Böhler T; Benner A; Krammer PH; Debatin KM
Cell Death Differ; 1998 Mar; 5(3):222-30. PubMed ID: 10200468
[TBL] [Abstract][Full Text] [Related]
8. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
Theze J
Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
[TBL] [Abstract][Full Text] [Related]
9. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
[TBL] [Abstract][Full Text] [Related]
10. Relationship of antibodies against CD4+ T cells in HIV-infected patients to markers of activation and progression: autoantibodies are closely associated with CD4 cell depletion.
Müller C; Kukel S; Bauer R
Immunology; 1993 Jun; 79(2):248-54. PubMed ID: 8102120
[TBL] [Abstract][Full Text] [Related]
11. The value of preserving HIV-specific immune responses.
Kaufmann DE; Rosenberg ES
J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
[TBL] [Abstract][Full Text] [Related]
12. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
[TBL] [Abstract][Full Text] [Related]
13. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.
Miedema F; Petit AJ; Terpstra FG; Schattenkerk JK; de Wolf F; Al BJ; Roos M; Lange JM; Danner SA; Goudsmit J
J Clin Invest; 1988 Dec; 82(6):1908-14. PubMed ID: 2974045
[TBL] [Abstract][Full Text] [Related]
14. High levels of human immunodeficiency virus infection of CD8 lymphocytes expressing CD4 in vivo.
Cochrane A; Imlach S; Leen C; Scott G; Kennedy D; Simmonds P
J Virol; 2004 Sep; 78(18):9862-71. PubMed ID: 15331721
[TBL] [Abstract][Full Text] [Related]
15. Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1.
Imlach S; McBreen S; Shirafuji T; Leen C; Bell JE; Simmonds P
J Virol; 2001 Dec; 75(23):11555-64. PubMed ID: 11689637
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity.
Samuelsson A; Broström C; van Dijk N; Sönnerborg A; Chiodi F
Virology; 1997 Nov; 238(2):180-8. PubMed ID: 9400591
[TBL] [Abstract][Full Text] [Related]
17. B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.
Cagigi A; Nilsson A; De Milito A; Chiodi F
Vaccine; 2008 Jun; 26(24):3016-25. PubMed ID: 18164520
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus and acquired immunodeficiency syndrome: an update.
Schnittman SM; Fauci AS
Adv Intern Med; 1994; 39():305-55. PubMed ID: 8140958
[TBL] [Abstract][Full Text] [Related]
19. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
